Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Abroad (travel likely)RecruitingPHASE2

Conditions

Lupus Nephritis (LN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China

Study leads

bicheng Liu
Principal Investigator
Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Membranous Nephropathy · Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Lupus Nephritis

Abroad (travel likely)RecruitingPHASE2

Syracuse, United States · San Antonio, United States

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

SLE · Systemic Lupus Erythematosus (SLE) · CAR T Cell

Abroad (travel likely)RecruitingPHASE1, PHASE2

Philadelphia, United States

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Lupus Nephritis · Primary Membranous Nephropathy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Little Rock, United States · Tustin, United States